Trevena (TRVN)
(Delayed Data from NSDQ)
$0.40 USD
-0.02 (-4.08%)
Updated May 24, 2024 03:56 PM ET
After-Market: $0.41 +0.01 (2.50%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (86 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.37 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -0.69 | 0.12 | 52.54 |
Next Quarter Estimate | -0.28 | 7.81 | 61.00 |
Next Year Estimate | -0.79 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 59.18 | 15.30 | 15.67 |
Next Year | 38.76 | 8.30 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 21.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 2.31 |
Price/Cash Flow (MRFY) | NA | 17.10 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -153.43% |
Return on Equity (TTM) | -1,018.15% | -58.74% |
Debt to Equity (MRQ) | -2.42 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.